Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial …

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD),
an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial …

To evaluate if the timing of appearance with respect to disease onset may influence the arthritis
presentation pattern in antisynthetase syndrome (ASSD). METHODS: The patients were …

Objective Arthritis, myositis and interstitial lung disease (ILD) constitute the classic clinical
triad of anti-synthetase syndrome (ASSD). These patients experience other accompanying …

Objective. In this multicentre study, we aimed to evaluate the capacity of a computer-assisted
automated QCT method to identify patients with SSc-associated interstitial lung disease (…

Background: Tofacitinib (TOFA) was the first Janus kinase inhibitor (JAKi) to be approved for
the treatment of rheumatoid arthritis (RA). However, data on the retention rate of TOFA …

This study’s aim was to describe: (a) How life-sustaining treatment (LST) decisions are made
for critically ill children in Italy; and (b) How these decisional processes are experienced by …

Purpose. Interstitial lung disease (ILD) related to systemic sclerosis (SSc) is assessed with
pulmonary functional tests (PFTs) and semi-quantitative scores based on extent of ILD …

Objectives This multicentre study aimed to investigate the overall mortality of combined
pulmonary fibrosis and emphysema (CPFE) in systemic sclerosis (SSc) and to compare CPFE-…